Ameritas Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Ameritas Advisory Services's VRTX Position: Q2 2026 in Review
Ameritas Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 72% in Q2 2026, selling an estimated $390K and leaving 337 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.
Ameritas Advisory Services first reported a position in VRTX in Q1 2023 and has held it in 8 quarters since. The position peaked at $835K in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Ameritas Advisory Services held 337 shares of Vertex Pharmaceuticals worth $167K as of Q2 2026.
- Ameritas Advisory Services sold 879 Vertex Pharmaceuticals shares in Q2 2026, an estimated $390K.
- Vertex Pharmaceuticals made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1108 holding.
- Ameritas Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 8 quarters since.
- Ameritas Advisory Services's Vertex Pharmaceuticals position peaked at $835K in Q4 2025.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.